Free Trial

Bayer Loses Latest Roundup Court Appeal

HEALTHCARE
  • Bayer's appeal to dismiss state-court claims on Roundup cancer warnings was rejected yesterday by an Atlanta Court of Appeals, impacting efforts to resolve litigation.
  • Bayer has won 10 of 16 recent Roundup trials though received a USD 2.25bn fine last week in Philadelphia with analysts suggesting that dividends may have to be lowered or suspended to meet litigation expenses.
  • Bayer argued that federal law, supported by the EPA's stance on glyphosate, should pre-empt state claims, but faces opposition and criticism for relying on this defence. The company is planning further legal actions, including seeking a Supreme Court ruling on the matter.
  • Bayer spreads are up to 3bps wider versus midswaps today while their equity is over 2% lower in early trading.
  • To read the full story

    Close

    Why MNI

    MNI is the leading provider

    of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

    Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.